Page last updated: 2024-10-27

fluorouracil and Lymphangioendothelioma, Malignant

fluorouracil has been researched along with Lymphangioendothelioma, Malignant in 1 studies

Fluorouracil: A pyrimidine analog that is an antineoplastic antimetabolite. It interferes with DNA synthesis by blocking the THYMIDYLATE SYNTHETASE conversion of deoxyuridylic acid to thymidylic acid.
5-fluorouracil : A nucleobase analogue that is uracil in which the hydrogen at position 5 is replaced by fluorine. It is an antineoplastic agent which acts as an antimetabolite - following conversion to the active deoxynucleotide, it inhibits DNA synthesis (by blocking the conversion of deoxyuridylic acid to thymidylic acid by the cellular enzyme thymidylate synthetase) and so slows tumour growth.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lawton, RL1
Gulesserian, HP1

Other Studies

1 other study available for fluorouracil and Lymphangioendothelioma, Malignant

ArticleYear
Complete regression of metastases following chemotherapy.
    Journal of surgical oncology, 1971, Volume: 3, Issue:2

    Topics: Aged; Cecal Neoplasms; Colectomy; Fluorouracil; Humans; Injections, Intravenous; Lung Neoplasms; Lym

1971